GALLIMUNE MG, injekcinė emulsija
GALLIMUNE MG, injekcinė emulsija
Authorised
- Mycoplasma gallisepticum, strain S6, Inactivated
Product identification
Medicine name:
GALLIMUNE MG, injekcinė emulsija
Active substance:
- Mycoplasma gallisepticum, strain S6, Inactivated
Target species:
-
Chicken
Route of administration:
-
Subcutaneous use
-
Intramuscular use
Product details
Active substance and strength:
-
Mycoplasma gallisepticum, strain S6, Inactivated1000000000.00/Colony forming unit0.30millilitre(s)
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Chicken
-
Meat and offal0day
-
-
Intramuscular use
- Chicken
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AB03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health Italia S.p.A.
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/99/1007/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 8/12/2022
RV1007.pdf
Lithuanian (PDF)
Download Published on: 10/06/2022
How useful was this page?:
